tis - will be good for the patient?

For us, the PATIENT shareholders, let's hope TIS successfully repairs the wounds of delay, surprise and uncertainty that we have endured over the last ?? months/years. (I have held for 4 years now).

However,

more and more I agree with Resourced's views. I don't think what is being asked for is unwarranted. Communicating with shareholders by the CEO is just a matter of spending 30 minutes between drinks on the B747 (or A380) typing the latest info. In a lot of cases the progres could be just "on course". But right now thinks are changing and evolving quickly, so there must be important steps being taken and put into place that we don't know about. I agree we don't HAVE to know these things, but for many people who have their hard-earned on the line, I think it is only respectful to keep them informed. I could even send SM a template to make it easier for him. Just fill in the x's.

Good morning Shareholders,

The following information about your company is provided so that you as owners and investors are aware of the latest state of play and plans during this important phase.

European Sales Preparations
xxxx xxxxx, xxxx xxxx etc.

FDA Trials Update
xxxxx xxxx, xxxx xxxx etc.

Planning and Revisions to Target Dates
xxxxx xxxx, xxxx xxxx etc.

Promotional Activities
xx xxxxxxx, xxxx xxxx etc.

Market Observations and Competitive Position
xx xxxxxxx, xxxx xxxx etc.

New Research
xx xxxxxxx, xxxx xxxx etc.

Thank you. The next update will be issued in early June 2012.
Stephen Mercer, CEO